Ahmed Y Aldryhim1,2, Abdulrahman Alomair1,3, Meshari Alqhtani1, Mansour A Mahmoud4,5, Thamir M Alshammari3,4,6, Lisa G Pont7, Khalid M Kamal8, Hisham Aljadhey3,4, Alemayehu B Mekonnen4, Monira Alwhaibi1,4, Bander Balkhi1, Tariq M Alhawassi1,4. 1. a Department of Clinical Pharmacy, College of Pharmacy, King Saud University , Riyadh , Saudi Arabia. 2. b Department of Pharmaceutics, College of Pharmacy, King Abdulaziz University , Jeddah , Saudi Arabia. 3. c National pharmacovigilance Center, Saudi Food and Drug Authority , Riyadh , Saudi Arabia. 4. d Medication Safety Research Chair, College of Pharmacy, King Saud University , Riyadh , Saudi Arabia. 5. e Department of Clinical Pharmacy, College of Pharmacy, Taibah University , Medina , Saudi Arabia. 6. f College of Pharmacy, Hail University , Hail , Saudi Arabia. 7. g Graduate School of Health, University of Technology Sydney , Broadway , Australia. 8. h Division of Pharmaceutical, Administrative and Social Sciences, Duquesne University School of Pharmacy , Pittsburgh , PA , USA.
Abstract
Objectives: Adverse drug reactions (ADRs) are a pervasive global problem, and its management is integral to patient safety and healthcare quality. Pharmacists play a pivotal role in monitoring and reporting ADRs, which has a direct impact on patient care. The aim of this study was to identify potential factors that facilitate pharmacists in community and hospital settings to report ADRs. Methods: A cross-sectional, online survey using a validated questionnaire was administered to pharmacists working in community and hospital pharmacies in Saudi Arabia. Results: 1,717 community and 153 hospital pharmacists participated in this study. Only 10.2% and 26.8% of community and hospital pharmacists, respectively, admitted ever reporting an ADR. The most reported factors that may facilitate ADRs reporting have included ongoing improvements in therapeutic knowledge about ADRs, attending educational programs with continuous medical education credits, the seriousness of the experienced ADRs and accessibility to patients' medical profile. The impact of peers by seeing colleagues reporting ADRs and ADRs due to herbal or traditional medicine were the least important factors reported by pharmacists. Conclusion: The study identified factors that can effectively address the under-reporting of ADRs by pharmacists. A multi-stakeholder, multi-pronged approach of ADR reporting is needed to develop greater awareness of this issue among pharmacists.
Objectives: Adverse drug reactions (ADRs) are a pervasive global problem, and its management is integral to patient safety and healthcare quality. Pharmacists play a pivotal role in monitoring and reporting ADRs, which has a direct impact on patient care. The aim of this study was to identify potential factors that facilitate pharmacists in community and hospital settings to report ADRs. Methods: A cross-sectional, online survey using a validated questionnaire was administered to pharmacists working in community and hospital pharmacies in Saudi Arabia. Results: 1,717 community and 153 hospital pharmacists participated in this study. Only 10.2% and 26.8% of community and hospital pharmacists, respectively, admitted ever reporting an ADR. The most reported factors that may facilitate ADRs reporting have included ongoing improvements in therapeutic knowledge about ADRs, attending educational programs with continuous medical education credits, the seriousness of the experienced ADRs and accessibility to patients' medical profile. The impact of peers by seeing colleagues reporting ADRs and ADRs due to herbal or traditional medicine were the least important factors reported by pharmacists. Conclusion: The study identified factors that can effectively address the under-reporting of ADRs by pharmacists. A multi-stakeholder, multi-pronged approach of ADR reporting is needed to develop greater awareness of this issue among pharmacists.
Authors: Lamyaa M Kassem; Bushra Alhabib; Khaledah Alzunaydi; Maryam Farooqui Journal: Int J Environ Res Public Health Date: 2021-04-07 Impact factor: 3.390